Calsarcin-1 also prevents angiotensin-II induced cardiac hypertrophy in a cardiac-specific transgenic mouse model, which underlines its role as an inhibitor of pathological hypertrophy [14]. The gene discussed is MYOZ2; the disease is cardiac hypertrophy.